Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01339871
Show Display Options
Rank Status Study
1 Recruiting Phase I Study of Pazopanib and Vorinostat
Condition: Advanced Cancer
Interventions: Drug: Pazopanib;   Drug: Vorinostat

Indicates status has not been verified in more than two years